high-intensity focused ultrasound (HIFU) anesthesia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Selective implementation of high-intensity focused ultrasound (HIFU) for gynecological benign tumors (mainly including uterine fibroids, adenomyosis and ovarian cysts); 2.ASA I-II grade; 3.18-50 years old
Exclusion criteria
Exclusion criteria: 1. Body mass index (BMI) = 30 kg/m2; 2. Contraindication to nerve block, including coagulation dysfunction (platelet 1.5, or being treated with anticoagulation), lumboback anatomical abnormalities, previous lumboback trauma or surgical history, puncture site infection, or severe chronic lumboback pain; 3.Spinal metastasis of suspected malignant tumor; 4. Chronic pain syndrome or current use of more than 60 mg of oral morphine or equivalent opioids per day; 5. Allergies to drugs associated with the study; 6. Lack of understanding of research process and evaluation; 7. Refuse to use plexus block analgesia; 8. Participated in other clinical trials 3 months before this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of moderate to severe pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Analgesic drug use;adverse event;Proportion of patients who got out of bed within 24 hours after HIFU treatment;time of first defecation after HIFU treatment;time of indwelling catheter;time from HIFU treatment to discharge;Patient satisfaction with analgesia; | — |
Countries
China
Contacts
West China Second University Hospital, Sichuan University